|
|
Toradol (Ketorolac Tromethamine) Tablets
|
 |
Central nervous system agent
|
 |
Analgesic
|
 |
Short-term (no more than 5 days) management of moderate to severe pain, usually following surgery.
|
 |
Adults and teens over 16: 10 mg, 4 times a day, taken every 4 to 6 hours. The dose should not exceed 40 mg a day.
|
 |
Category C
|
 |
Headache, GI pain, drowsiness, dizziness, itching, rash, water retention, Ringing in the Ears, hives, peptic ulcer, GI bleeding, Hypertension, worsening of Asthma, unusual bruises on the skin
|
Pregnancy Risk Categories defined:
A: Studies in pregnant women failed to show a risk to the fetus in the first
trimester - with no evidence of risk in the later trimesters.
B: Animals studies indicate no adverse effect to the fetus, but there are no adequate,
clinical studies in pregnant women.
C: Animal studies have shown an adverse effect on the fetus, but there are no adequate,
clinical studies in humans. Despite potential risks, the drug may be useful in pregnant
women.
D: There is evidence of risk to the human fetus, but the potential benefits of use in
pregnant women may be acceptable, despite potential risks.
X: Studies in animals or humans show fetal abnormalities, or adverse reaction reports
indicate evidence of fetal risk. Warning: the risks involved clearly outweigh any
potential benefit from using the drug in pregnant women, regardless of trimester.
NR: Not rated (i.e., no information available at this time as to the potential
risks or benefits).
|
| | |
If you want your friend to read or know about this article, Click here
 |
|
|
